The role of cannabinoids and endocannabinoid system in the treatment of epilepsy

Agar E.:The role of cannabinoids and leptin in neurological diseases. Acta Neurologica Scandinavica, 2015, 132: 371–80.10.1111/ane.12411Search in Google Scholar

Alexander S.P.:Therapeutic potential of cannabis-related drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2015, 64: 157–166.10.1016/j.pnpbp.2015.07.001Search in Google Scholar

Ameri A.:The effect of cannabinoids on the brain. Progress in neurobiology, 1999, 58: 315–34810.1016/S0301-0082(98)00087-2Search in Google Scholar

Ames F.R., Cridland S.:Anticonvulsant effect of cannabidiol. South African Medical Journal, 1985, 69: 14.Search in Google Scholar

Benbadis S.R., Sanchez-Ramos J., Bozorg A., Giarratano M., Kalidas K., Katzin L. et al.:Medical marijuana in neurology. Expert Review of Neurotherapeutic, 2014, 14: 1453–1465.10.1586/14737175.2014.985209Search in Google Scholar

Brown A.J.:Novel cannabinoid receptor. Br. J. Pharmacol., 2007, 152: 567–575.10.1038/sj.bjp.0707481Search in Google Scholar

Colasanti B.K., Lindamood C., Craig C.R.:Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacology, Biochemistry, and Behavior, 1982, 16: 573–578.10.1016/0091-3057(82)90418-XSearch in Google Scholar

Consroe P., Benedito M.A., Leite J.R., Carlini E.A., Mechoulam R.:Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice. European Journal of Pharmacology, 1982, 83: 293–298.10.1016/0014-2999(82)90264-3Search in Google Scholar

Consroe P., Wolkin A.:Cannabidiol – antiepileptic drug comparisons and interactions in experimentally induced seizures in rats. The Journal of Pharmacology and Experimental Therapeutics, 1977, 201: 26–32.Search in Google Scholar

Cunha J.M., Carlini E.A., Pereira A.E., Ramos O.L., Pimentel C., Gagliardi R. et al.:Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology, 1980, 21: 175–185.10.1159/0001374307413719Search in Google Scholar

Dąbrowska K., Miturska E., Moskalewicz J.:The consequences of marijuana use and abuse – a review. Alkoholizm i Nar-komania, Instytut Psychiatrii i Neurologii, 2012, 25: 167–186.Search in Google Scholar

Devinsky O., Cilio M.R., Cross H., Fernandez-Ruiz J., French J., Hill C. et al.:Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 2014, 55: 791–802.10.1111/epi.12631470766724854329Search in Google Scholar

Friedman D., Devinsky O.:“Cannabinoids in the treatment of epilepsy”. N. Engl. J. Med., 2015, 373, 1048–1058.10.1056/NEJMra140730426352816Search in Google Scholar

Gloss D., Vickrey B.:Cannabinoids for epilepsy. Cochrane Database Sys. Rev. 2014; CD00927010.1002/14651858.CD009270.pub3Search in Google Scholar

Goldenberg M.M.:Overview of Drugs Used For Epilepsy. Seizures, Etiology, Diagnosis, and Treatment. Pharmacy and Therapeutics, 2010, 35: 392–415.Search in Google Scholar

Gordon E., Devinsky O.:Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia, 2001, 42: 1266–1272.10.1046/j.1528-1157.2001.19301.xSearch in Google Scholar

Hall.W., Degenhardt L .:Adverse health effects of non-medical cannabis use. Lancet 2009, 17, 374: 1383–139110.1016/S0140-6736(09)61037-0Search in Google Scholar

Hamerle M., Ghaeni L., Kowski A., Weissinger F., Holtkamp M.:“Cannabis and other illicit drug use in epilepsy patients”. Eur. J. Neurol., 2014, 21: 167–170.10.1111/ene.1208123311572Search in Google Scholar

Hegde M., Santos-Sanchez C., Hess C.P., Kabir A.A., Garcia P.A.:Seizure exacerbation in two patients with focal epilepsy following marijuana cessation. Epilepsy and Behavior, 2012, 25: 563–566.10.1016/j.yebeh.2012.09.02423159379Search in Google Scholar

Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R. et al.:Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences USA, 1990, 87: 1932–1936.10.1073/pnas.87.5.1932535982308954Search in Google Scholar

Hill A.J, Williams C.M., Whalley B.J., Stephens G.J.:Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacology and Therapeutics, 2012, 133: 79–97.10.1016/j.pharmthera.2011.09.00221924288Search in Google Scholar

Izzo A.A., Borrelli F., Capasso R., Di Marzo V., Mechoulam R.:Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences, 2009, 30: 515–527.10.1016/j.tips.2009.07.00619729208Search in Google Scholar

Jędrzejko M.:Marihuana fakty. Marihuana mity. Wrocławskie Wydawnictwo Naukowe Atla2, Wrocław 2011.Search in Google Scholar

Jones N. A., Hill A. J., Smith I., Bevan S. A., Williams C. M., Whalley B. J. et al .:Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. Journal Pharmacology and Experimental Therapeutics, 2010, 332: 569–577.10.1124/jpet.109.159145281983119906779Search in Google Scholar

Karabowicz P., Grzęda E., Baranowicz-Kuczko M., Malinowska B.:Role of endocannabinoid 2-arachidonylglycerol in the physiology and pathophysiology of the cardiovascular system. Postępy Hig. Med. Dosw (online), 2014, 68: 814–827.10.5604/17322693.110887524934539Search in Google Scholar

Koppel B.S., Brust J.C.M., Fife T., Bronstei J., Youssof S., Gronseth G. et al:“Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology” Neurology, 2014, 82: 1556–1563.10.1212/WNL.0000000000000363Search in Google Scholar

Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Allen Hauser W., Mathern G. et al.:Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 2010, 51: 1069–1077.10.1111/j.1528-1167.2009.02397.xSearch in Google Scholar

Löscher W.:Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Research, 2002, 50: 105–123.10.1016/S0920-1211(02)00073-6Search in Google Scholar

Lozano I.:The therapeutic use of Cannabis sativa L. in Arabic medicine. Journal of Cannabis Therapeutics, 2001, 1: 63–70.10.1300/J175v01n01_05Search in Google Scholar

Lutz B.:On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochemical Pharmacology, 2004, 68: 1691–1698.10.1016/j.bcp.2004.07.00715450934Search in Google Scholar

Maa E., Figi P.:The case for medical marijuana in epilepsy. Epilepsia, 2014, 55: 783–786.10.1111/epi.1261024854149Search in Google Scholar

Mathern G., Nehlig A., Sperling M.:Cannabidiol and medical marijuana for the treatment of epilepsy. Epilepsia, 2014, 55: 781–782.10.1111/epi.1264724854631Search in Google Scholar

Mechoulam R., Carlini E.A:Toward drugs derived from cannabis. Naturwissenschaften, 1978, 65: 174–179.10.1007/BF00450585351429Search in Google Scholar

Mechoulam R.:The pharmacohistory of Cannabis sativa. Cannabinoids as therapeutic agents. Boca Raton, 1986, CRC Press; 1–20.10.1201/9780429260667-1Search in Google Scholar

Mikuriya T.H.:Marijuana in medicine: past, present and future. California Medicine, 1969, 110:34–40.Search in Google Scholar

Ng S.K., Brust J.C., Hauser W.A., Susser M.:Illicit drug use and the risk of new-onset seizures. American Journal of Epidemiology. 1990, 132: 47–57.10.1093/oxfordjournals.aje.a1156422356813Search in Google Scholar

O’Shaughnessy W.B.:On the Preparations of the Indian Hemp, or Gunjah. Trans. Med. Phys. Soc. Bombay, 1842, 8: 421–461.Search in Google Scholar

O’Shaughnessy W.B.:The Bengal Dispensatory and Companion to the Pharmacopoeia. Allen, London 1842.Search in Google Scholar

Ożarowski M., Mikołajczak P.Ł., Bogacz A., Bartkowiak-Wieczorek J., Kujawski R.:Progress in study of Cannabis sativa leaves extracts without psychotropic cannabinoids in animal model of neuropathic pain. Journal of Medical Science, 2014, 4: 328–33510.20883/medical.e88Search in Google Scholar

Pacher P., Bátkai S., Kunos G.:The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Review, 2006, 58: 389–462.10.1124/pr.58.3.2Search in Google Scholar

Pertwee R.G.:The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta 9-tetrahydrocannabivarin. British Journal of Pharmacology, 2008, 153: 199–215.10.1038/sj.bjp.0707442Search in Google Scholar

Pertwee R.G., Howlett A.C., Abood M.E., Alexander S.P., Di Marzo V., Elphick M.R. et al.:International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacological Reviews, 2010, 62: 588–631.Search in Google Scholar

Porter B.E., Jacobson C.:Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy and behavior, 2013, 29: 574–577.10.1016/j.yebeh.2013.08.037Search in Google Scholar

Radwan M.M., Elshohly M.A., Slade D., Ahmed S.A., Khan I.A., Ross S.A.:Biologically active cannabinoids from high potency Cannabis sativa. Journal Natural Products, 2009, 72: 906–911.10.1021/np900067kSearch in Google Scholar

Reynolds J.R.:Therapeutic uses and toxic effects of Cannabis indica. Lancet, 1890, 1: 637–638.10.1016/S0140-6736(02)18723-XSearch in Google Scholar

Russo E.B.:Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 2011, 163: 1344–1364.10.1111/j.1476-5381.2011.01238.x316594621749363Search in Google Scholar

Ryberg E., Larsson N., Sjogren S., Hjorth S., Hermansson N.O., Leonova J.:The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol., 2007, 152: 1092–1101.10.1038/sj.bjp.0707460209510717876302Search in Google Scholar

Rymanowski M.:Cannabis – review of the issues related to determination of the total content of delta-9-tetrahydrocannabinol (Δ-9-THC) and delta 9-tetrahydrocannabinolic acid (Δ-9-THCA-A). Problemy Kryminalistyki, 2014, 285: 1–18.10.34836/pk.2014.285.1Search in Google Scholar

Santos R.G., Hallak J.E., Leite J.P., Zuardi A.W., Crippa J.A.:Phytocannabinoids and epilepsy. Journal Clinical Pharmacy and Therapeutics, 2015, 40: 135–143.10.1111/jcpt.1223525475762Search in Google Scholar

Shore D.M., Reggio P.H .:The therapeutic potential of orphan GPCRs, GPR35 and GPR55. Frontiers in Pharmacology, 2015, 6:69. doi: 10.3389/fphar.2015.0006910.3389/fphar.2015.00069439772125926795Search in Google Scholar

Shaw J.:On the use of Cannabis indica in tetanus hydrophobia, and in cholera with remarks on its effects. Madras Med. J., 1843, 5: 74–80.Search in Google Scholar

Stanley C.P., Hind W.H., Tufarelli C., O’Sullivan S.E.:Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation. Cardiovascular Research, 2015, 107: 568–578.10.1093/cvr/cvv179454014426092099Search in Google Scholar

Sugiura T., Waku K .:Cannabinoid receptors and their endogenous ligands. Journal of Biochemistry, 2002, 132: 7–12.10.1093/oxfordjournals.jbchem.a00320012097154Search in Google Scholar

Szaflarski J.P., Bebin E.M.:Cannabis, cannabidiol, and epilepsy – from receptors to clinical response. Epilepsy Behavior, 2014, 41: 277–82.10.1016/j.yebeh.2014.08.13525282526Search in Google Scholar

Szukalski B.:Kannabinoidy. Kompendium wiedzy o środkach uzależniających. Wyd. Instytutu Psychiatrii i Neurologii, Warszawa 2005.Search in Google Scholar

Trembly B., Sherman M.:Double-blind clinical study of cannabidiol as a secondary anticonvulsant. Marijuana ‘90 International Conference on Cannabis and Cannabinoids,199O July 8–11, Kolympari, Crete. International Association for Cannabinoid Medicines, 1990: section 2, p. 5.Search in Google Scholar

Turkanis S.A., Smiley, K.A., Borys H.K., Olsen D.M., Karler R.:An Electrophysiological Analysis of the Anticonvulsant Action of Cannabidiol on Limbic Seizures in Conscious Rats. Epilepsia, 1979, 20: 351–363. doi:10.1111/j.1528-1157.1979.tb04815.x10.1111/j.1528-1157.1979.tb04815.x477630Search in Google Scholar

Wallace M.J., Blair R.E., Falenski K.W., Martin B.R., DeLorenzo R.J.:The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. The Journal of Pharmacology and Experimental Therapeutics, 2003, 307: 129–137.10.1124/jpet.103.05192012954810Search in Google Scholar

Wilkinson J.D., Whalley B.J., Baker D., Pryce G., Constanti A., Gibbons S. et al.:Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects? The Journal of Pharmacy and Pharmacology, 2003, 55: 1687–1694 doi:10.1211/002235702230410.1211/002235702230414738597Search in Google Scholar

Wolff V., Armspach J.P., Lauer V., Rouyer O., Bataillard M. et al.:Cannabis-related stroke: myth or reality? Stroke, 2013, 44: 558–563.10.1161/STROKEAHA.112.67134723271508Search in Google Scholar

Zhornitsky S., Potvin S.:Cannabidiol in humans-the quest for therapeutic targets. Pharmaceuticals (Basel), 2012, 5: 529–552.10.3390/ph5050529376364924281562Search in Google Scholar

Zuardi A.W., Crippa J.A., Hallak J.E., Moreira F.A., Guimaraes F.S.:Cannabidiol, Cannabis sativa constituent, as an antipsychotic drug. Braz. J. Med. Biol. Res., 2006, 39: 421–429.10.1590/S0100-879X200600040000116612464Search in Google Scholar